Related Experiment Video
Updated: Mar 3, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
What happened to Koch's postulates in diarrhoea?
Shamima Sultana1, Shafiqul A Sarker1, Harald Brüssow2
1Clinical Sciences Department, International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Robert Koch's postulates for infectious disease etiology have evolved. New findings suggest gut microbiota imbalance (dysbiosis) is crucial alongside pathogens and host factors in causing disease.
Area of Science:
- Microbiology
- Infectious Diseases
- Gut Microbiome Research
Background:
- Robert Koch's postulates, established in 1890, define criteria for identifying infectious disease agents.
- Understanding of infectious disease pathogenesis has evolved, necessitating revisions to Koch's postulates.
- The role of host commensal microbiota in disease development is a recent area of focus.
Purpose of the Study:
- To review the historical development of Koch's postulates.
- To analyze diarrhea etiology in Bangladesh concerning Koch's postulates.
- To investigate the influence of gut microbiota on infectious disease causation.
Main Methods:
- Historical overview of Koch's postulates.
- Analysis of etiological data for diarrhea in Bangladesh.
- Examination of the relationship between pathogens, microbiota, and disease.
Main Results:
- In areas with poor hygiene, bacterial enteropathogens are necessary but not sufficient for diarrhea.
- Loss of gut microbiota equilibrium (dysbiosis) emerges as a significant co-factor in pathogen-induced diarrhea.
- The traditional '1 pathogen + 1 host = 1 disease' model is insufficient.
Conclusions:
- Koch's postulates require updating to incorporate the role of the gut microbiome.
- Infectious disease etiology is multifactorial, involving pathogens, local environment, and host susceptibility.
- A revised model, 'X (pathogen/s) + Y (local milieu) + Z (host susceptibility) = disease', better reflects complex pathogenesis.
More Related Videos
08:23Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: